Ticker Details
United Therapeutics Corporation United Therapeutics Corp is engaged in the healthcare sector. Its core offering includes pharmaceutical products to address unmet medical needs of patients.
IPO Date:	June 17, 1999
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$24.13B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.77 | 1.39%
Avg Daily Range (30 D):	$5.77 | 1.00%
Avg Daily Range (90 D):	$6.54 | 1.23%

Institutional Daily Volume
Avg Daily Volume:	.52M
Avg Daily Volume (30 D):	.33M
Avg Daily Volume (90 D):	.39M

Trade Size
Avg Trade Size (Sh.):	84
Avg Trade Size (Sh.) (30 D):	22
Avg Trade Size (Sh.) (90 D):	22

Institutional Trades
Total Institutional Trades:	14,545
Avg Institutional Trade:	$5.45M
Avg Institutional Trade (30 D):	$26.99M
Avg Institutional Trade (90 D):	$32.28M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$10.51M
Avg Closing Trade (30 D):	$38.51M
Avg Closing Trade (90 D):	$38.45M
Avg Closing Volume:	59.36K

News

May 19, 2026 @ 5:00 PM Pulmonary Arterial Hypertension Clinical Trial Pip... Source: Delveinsight

May 5, 2026 @ 12:00 PM Transplants.org Launches as Centralized Education ... Source: Not Specified

Apr 8, 2026 @ 5:00 PM Interstitial Lung Disease Market to Witness Accele... Source: Delveinsight

Mar 30, 2026 @ 4:40 PM Stocks Rise As Powell's Remarks Cool Rate Fears: W... Source: Piero Cingari

Mar 30, 2026 @ 2:08 PM Why Is United Therapeutics Stock Soaring Monday? Source: Vandana Singh

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$29.27	$6.32
Diluted EPS	$27.07	$5.82
Revenue	$3.17B	$781.5M
Gross Profit	$2.74B	$648.1M
Net Income / Loss	$1.29B	$274.9M
Operating Income / Loss	$1.44B	$325.8M
Cost of Revenue	$425.3M	$133.4M
Net Cash Flow	$-620.2M	$-277.4M
PE Ratio

Splits
Sep 23, 2009	2:1